Monograph Criteria Eligibility, Poison Treatment Proposals Lead OTC Agenda
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed rule on eligibility criteria for additional monograph indications and a proposed amendment to the monograph on poison treatment products lead the list of OTC review documents that appear to be furthest along at the agency, according to FDA's "unified agenda," published in the April 26 Federal Register.